Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Tilray Inc buy PlusUltra

Tilray Inc
Start price
€9.18
01.11.21 / 0%
Target price
-
01.11.22
Performance (%)
-63.46%
End price
€3.35
15.09.22
Summary
This prediction ended on 15.09.22 with a price of €3.35. The BUY prediction by PlusUltra for Tilray Inc performed very badly with a performance of -63.46%. This prediction was marked as speculative and is excluded from PlusUltra's performance statistics.

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y
Tilray Inc -14.105% -14.105% -78.620%
iShares Core DAX® -1.785% -1.250% 11.664%
iShares Nasdaq 100 -2.154% 0.300% 37.531%
iShares Nikkei 225® -4.028% -3.746% 17.142%
iShares S&P 500 -1.969% 0.307% 25.617%

According to PlusUltra what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Revenue growth >5% per year expected
Cons
Probably not worthwhile Investment
Below average Management
No Innovation
Below average Marketposition

Comments by PlusUltra for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) -63.46%
Target price
Change
Ends at 01.11.22

Buy Tilray Inc

PlusUltra 
0
Report Share
01.11.21

Stopped prediction by PlusUltra for Tilray Inc

sell
Tilray Inc

Start price
Target price
Perf. (%)
€9.55
03.10.21
-
03.10.22
-3.92%
01.11.21

Revenue growth >5% per year expected
Probably not worthwhile Investment
Below average Management
No Innovation
PlusUltra 
03.10.21 0%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€35.17
09.02.21
€35.00
09.02.22
-72.84%
03.10.21

Revenue growth >5% per year expected
Probably not worthwhile Investment
Below average Management
No Innovation
PlusUltra 
09.02.21 80%